CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
CVS Health (CVS) Stock Moves -1.42%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $93.20 in the latest trading session, marking a -1.42% move from the prior day.
Here's Why Investors Should Retain CVS Health (CVS) For Now
by Zacks Equity Research
Investors are optimistic about CVS Health's (CVS) robust revenue growth across its operating segments.
Is Franklin U.S. Low Volatility H (LVHD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for LVHD
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $91.29 in the latest trading session, marking a +0.23% move from the prior day.
Top Stock Reports for Apple, NVIDIA & McDonald's
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), NVIDIA Corporation (NVDA), and McDonald's Corporation (MCD).
CVS Health (CVS) Stock Moves -1.75%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $89.85 in the latest trading session, marking a -1.75% move from the prior day.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $91.45, marking a +0.89% move from the previous day.
Amid Volatility, These 3 Blue-Chip Stocks Provide a Valuable Layer of Defense
by Derek Lewis
Blue-chip stocks are well-established companies that have consistently provided reliability and the ability to operate profitably in both good and bad times.
CVS Health (CVS) Stock Moves -1.21%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $92.74, moving -1.21% from the previous trading session.
CVS Health (CVS) Down 0.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CVS Health (CVS) to Improve Primary Care With New Offering
by Zacks Equity Research
CVS Health (CVS) debuts the new CVS Health Virtual Primary Care solution to allow consumers to obtain care whenever necessary.
The Zacks Analyst Blog Highlights JPMorgan Chase, Gilead Sciences, CSX, CVS Health and China Petroleum & Chemical
by Zacks Equity Research
JPMorgan Chase, Gilead Sciences, CSX, CVS Health and China Petroleum & Chemical have been included in this Analyst Blog.
Top Research Reports for JPMorgan, Gilead Sciences & CSX
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Gilead Sciences, Inc. (GILD) and CSX Corporation (CSX).
Should Legg Mason Low Volatility High Dividend ETF (LVHD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for LVHD
Walmart, Costco, CVS, and Target are part of Zacks Earnings Preview
by Zacks Equity Research
Walmart, Costco, CVS, and Target are highlights of Zacks Earnings Preview article.
Previewing Retail Sector Earnings as Inflation Climbs
by Sheraz Mian
With respect to the Retail sector's 2022 Q1 earnings season scorecard, we now have results from 21 of the 34 retailers in the S&P 500 index. Here's how the companies are performing so far and what to expect...
Here's Why You Should Hold on to CVS Health (CVS) For Now
by Zacks Equity Research
Investors are optimistic about CVS Health's (CVS) better-than-expected results and strong retail sales.
The Zacks Analyst Blog Highlights AbbVie, Qualcomm, Linde, CVS Health Corp, and Booking Holdings
by Zacks Equity Research
AbbVie, Qualcomm, Linde, CVS Health Corp, and Booking Holdings are part of Zacks top Analyst Blog.
Q1 Earnings Scorecard and Analyst Reports for AbbVie, QUALCOMM & Linde
by Sheraz Mian
Today's Research Daily features a real-time update on the Q1 earnings season and new research reports on AbbVie (ABBV), QUALCOMM (QCOM), and Linde(LIN).
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
CVS Health (CVS) Q1 Earnings Top Estimates, '22 EPS View Up
by Zacks Equity Research
CVS Health (CVS) reports better-than-expected results for Q1, with robust segmental performance driving the top line.
CVS Health (CVS) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 3.74% and 1.71%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Herbalife LTD. (HLF) Q1 Earnings Beat Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of 13.79% and 2.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Can CVS Health (CVS) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
TravelCenters of America (TA) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
TravelCenters (TA) delivered earnings and revenue surprises of 2,160% and 4.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?